• Return to Headlines

Array Biopharma Shares Up 96.3% Since SmarTrend's Buy Recommendation (ARRY)

By David Diaz

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 12 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

In the past 52 weeks, shares of Array Biopharma have traded between a low of $20.72 and a high of $47.98 and are now at $47.85, which is 131% above that low price. The 200-day and 50-day moving averages have moved 0% lower and 0% lower over the past week, respectively.

Array BioPharma Inc. operates as a discovery research company creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Array Biopharma shares.

Log in and add Array Biopharma (ARRY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights Array BioPharma

Ticker(s): ARRY